{"id":60818,"date":"2025-02-20T19:02:24","date_gmt":"2025-02-20T18:02:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/"},"modified":"2025-02-20T19:02:24","modified_gmt":"2025-02-20T18:02:24","slug":"applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/","title":{"rendered":"Applied Policy Welcomes Linda Rouse O\u2019Neill as VP of Health Policy"},"content":{"rendered":"<div>\n<p>ALEXANDRIA, Va.&#8211;(BUSINESS WIRE)&#8211;Applied Policy is pleased to announce the appointment of Linda Rouse O\u2019Neill as Vice President of Health Policy specializing in medical device coverage, coding and reimbursement. O\u2019Neill brings in-depth understanding of regulatory and legislative issues affecting the healthcare sector, informed by more than 30 years of experience in government affairs and healthcare policy.\n<\/p>\n<p>\nBefore joining Applied Policy, O\u2019Neill spent 14 years at the Health Industry Distributors Association (HIDA), rising to Senior Vice President of Healthcare Policy. Throughout her tenure, she worked closely with medical product manufacturers and distributors to address key supply chain challenges, including tariffs, transportation, domestic production, and Medicare reimbursement. She also cultivated strong partnerships with the Administration for Strategic Preparedness and Response (ASPR), managing a $2 million collaborative agreement.\n<\/p>\n<p>\nO\u2019Neill previously worked on Capitol Hill as a legislative assistant to a member of the Senate Finance Committee, analyzing and advising on health legislation and amendments. Her focus on rural provider reimbursement during this period extended to serving as co-staff director for the Senate Rural Health Caucus. She later served as Director of Federal Affairs for one of the nation\u2019s largest group purchasing organizations, leading policy initiatives on value-based purchasing, hospital infection control, and unique device identification.\n<\/p>\n<p>\n<i>&#8220;Linda\u2019s deep understanding of healthcare policy and supply chain dynamics makes her an invaluable addition to Applied Policy,&#8221; said James Scott, President and CEO of Applied Policy. \u201cHer expertise will strengthen our ability to support clients navigating the complexities of medical device regulations and reimbursement policies.&#8221;<\/i>\n<\/p>\n<p>\nO\u2019Neill holds a Bachelor of Arts in American History and Journalism from the University of Albany and a Master of Arts in Legislative Affairs from The George Washington University.\n<\/p>\n<p>\n<b>About Applied Policy<\/b>\n<\/p>\n<p>\nApplied Policy is a leading firm specializing in CMS reimbursement issues and related health policy. It was founded in 2009 by James Scott. Scott brings experience at CMS, on Capitol Hill and with an international pharmaceutical firm to his role.\n<\/p>\n<p>\nFor more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.appliedpolicy.com%2F&amp;esheet=54211088&amp;newsitemid=20250220060400&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.appliedpolicy.com%2F&amp;index=1&amp;md5=5e280dd9f814b3c007f2e2a614964a41\" rel=\"nofollow\" shape=\"rect\">https:\/\/www.appliedpolicy.com\/<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nFor media inquiries, contact:<br \/>\n<br \/>Louisa Hart, Communications Consultant<br \/>\n<br \/><a target=\"_blank\" href=\"mai&#108;&#116;&#111;&#58;&#x6c;&#x68;&#x61;&#x72;&#x74;&#x40;&#x61;ppl&#105;&#101;&#100;&#112;&#111;&#x6c;&#x69;&#x63;&#x79;&#x2e;&#x63;om\" rel=\"nofollow\" shape=\"rect\">&#x6c;&#104;&#x61;&#x72;&#116;&#x40;&#97;p&#x70;&#108;i&#x65;&#100;p&#x6f;&#108;i&#x63;&#121;&#x2e;&#x63;&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALEXANDRIA, Va.&#8211;(BUSINESS WIRE)&#8211;Applied Policy is pleased to announce the appointment of Linda Rouse O\u2019Neill as Vice President of Health Policy specializing in medical device coverage, coding and reimbursement. O\u2019Neill brings in-depth understanding of regulatory and legislative issues affecting the healthcare sector, informed by more than 30 years of experience in government affairs and healthcare policy. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60818","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Applied Policy Welcomes Linda Rouse O\u2019Neill as VP of Health Policy - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Applied Policy Welcomes Linda Rouse O\u2019Neill as VP of Health Policy - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ALEXANDRIA, Va.&#8211;(BUSINESS WIRE)&#8211;Applied Policy is pleased to announce the appointment of Linda Rouse O\u2019Neill as Vice President of Health Policy specializing in medical device coverage, coding and reimbursement. O\u2019Neill brings in-depth understanding of regulatory and legislative issues affecting the healthcare sector, informed by more than 30 years of experience in government affairs and healthcare policy. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T18:02:24+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Applied Policy Welcomes Linda Rouse O\u2019Neill as VP of Health Policy\",\"datePublished\":\"2025-02-20T18:02:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\\\/\"},\"wordCount\":357,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\\\/\",\"name\":\"Applied Policy Welcomes Linda Rouse O\u2019Neill as VP of Health Policy - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2025-02-20T18:02:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Applied Policy Welcomes Linda Rouse O\u2019Neill as VP of Health Policy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Applied Policy Welcomes Linda Rouse O\u2019Neill as VP of Health Policy - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/","og_locale":"en_US","og_type":"article","og_title":"Applied Policy Welcomes Linda Rouse O\u2019Neill as VP of Health Policy - Pharma Trend","og_description":"ALEXANDRIA, Va.&#8211;(BUSINESS WIRE)&#8211;Applied Policy is pleased to announce the appointment of Linda Rouse O\u2019Neill as Vice President of Health Policy specializing in medical device coverage, coding and reimbursement. O\u2019Neill brings in-depth understanding of regulatory and legislative issues affecting the healthcare sector, informed by more than 30 years of experience in government affairs and healthcare policy. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/","og_site_name":"Pharma Trend","article_published_time":"2025-02-20T18:02:24+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Applied Policy Welcomes Linda Rouse O\u2019Neill as VP of Health Policy","datePublished":"2025-02-20T18:02:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/"},"wordCount":357,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/","url":"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/","name":"Applied Policy Welcomes Linda Rouse O\u2019Neill as VP of Health Policy - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2025-02-20T18:02:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/applied-policy-welcomes-linda-rouse-oneill-as-vp-of-health-policy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Applied Policy Welcomes Linda Rouse O\u2019Neill as VP of Health Policy"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60818"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60818\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}